Skip to main content
Tech.euFundingExplorerBeta

The Commission for Technology and Innovation - CTI

Investor profile

The Commission for Technology and Innovation - CTI has backed 2 European tech companies across 2 funding rounds in 2016, joining rounds totalling €2.0M. Most active in Healthtech and Hardware. Data as of 4 Nov 2026.

Deals
2
distinct rounds
Companies
2
backed
Active span
2016
1 yr
Total round €
€2.0M
sum of rounds joined

Deals by year

distinct rounds / year
The Commission for Technology and Innovation - CTI — deals by year — interactive chart.
Data table
The Commission for Technology and Innovation - CTI — deals by year
20162

Top sectors

by deals
The Commission for Technology and Innovation - CTI — top sectors — interactive chart.
Data table
The Commission for Technology and Innovation - CTI — top sectors
Healthtech1
Hardware1

Stages

by deals
The Commission for Technology and Innovation - CTI — stages — interactive chart.
Data table
The Commission for Technology and Innovation - CTI — stages
Seed1
Series A1

Countries

by deals
The Commission for Technology and Innovation - CTI — countries — interactive chart.
Data table
The Commission for Technology and Innovation - CTI — countries
Switzerland2

Co-investment network

shared rounds
Co-investment network — interactive chart.
The Commission for Technology and Innovation - CTI — 2 dealsThe Commission for Technology and Innovation - CTIEuroStars — 1 shared deals · click to openEuroStarsFTI Group — 1 shared deals · click to openFTI GroupPatrick Delarive — 1 shared deals · click to openPatrick DelarivePolytech Ecosystem Venture — 1 shared deals · click to openPolytech Ecosystem VentureSICPA Finance — 1 shared deals · click to openSICPA Finance

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
TopadurSwitzerland1€2.0M
BIOWATCHSwitzerland1€0

Biggest deals

top 10 by amount
CompanyStageAmountDate
TopadurSeries A€2.0M2016-04
BIOWATCHSeed—2017-01
← Back to investors